Adverse events reporting is crucial

It’s interesting how underreported adverse events can compromise patient safety. In fact, a study highlighted that nearly 95% of serious events stay unreported in some scenarios. How do you all ensure effective monitoring in your research?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌​​⁠​‌​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​⁠‍‌‌‌⁠‌​​‌‌‌​⁠‌‍‍‍‌‍‌⁠‌‌‍​‌​‍‍‌⁠‍​‌​‌​​⁠‌‍‌‍‌​‌‌​‍‌​​‍‌​⁠​‌⁠​‍​‍​‍‌⁠⁠‌​

Underreporting adverse events is a huge issue, especially when you think about how ‘nearly 95%’ go unreported. In my experience, regular training sessions for our site staff have really boosted awareness and compliance. What strategies does your team use to encourage consistent reporting?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‌‌​⁠​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌​​⁠​‍​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‍‌​‍⁠‌‌​​⁠‌​⁠⁠‌⁠‌⁠​⁠​⁠‌‍‌​‌​‍⁠​⁠‍​‌​​‌‌‌​‌‌​‌​‌​‍‍‌‌‌​‌‍⁠‍‌‍‌‍​‍​‍‌⁠⁠‌

It’s maddening how many serious events go unreported, right? We’ve found that implementing a more streamlined reporting tool has made a big difference in capturing these events. I wonder if anyone else has tried similar tech solutions or what kind of training works best for them?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‌‌​⁠​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌​​⁠​⁠​⁠​​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‌⁠‌​‌⁠​⁠‌⁠‌‌‍‍‌‍⁠‍‌⁠‍‍​⁠‌⁠‌‍​‍‌‍‍‌‌​‍‌‌‌‍‍‌⁠​​‌‌‍‌‌​‌‍​⁠‌⁠‌​‌⁠​‍​‍‌⁠⁠‌

It’s crucial to establish a culture of transparency at the site. In our last study, we had regular feedback sessions where staff could discuss issues, which really improved our adverse event reporting. I totally agree that training is key — what methods have you found effective?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‌‌​⁠​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​​​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌⁠‍​‌‌​⁠‌​‌‍​⁠‍​‌‍⁠⁠‌⁠​‍‌​⁠‌​⁠‍‌‌​⁠​‌‍⁠‍‌​⁠‌‌⁠‌⁠‌​‌‍‌‌​‍‌​‌‍​‍​‍‌⁠⁠‌